Access · International · continued
What changed in 2026, by region posts 121–123
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more predictive than theory.
0 likes 18mo
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Language barriers in accessing a prescription abroad
Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
|
2 | 22k | 1h | |
|
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
|
+131 | 148 | 28k | 5mo |
|
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+104 | 114 | 6.1k | 3h |
|
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. Documenting an access outcome, dated, because…
|
+135 | 139 | 8.7k | 16mo |
|
Cross-border purchase within the EU: the actual rules
Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is…
|
+6 | 10 | 41k | 11mo |
Related topics — sharing the tags EMA, NHS, personal import
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cross-border purchase within the EU: the actual rules
Cross-border purchase within the EU: the actual rules Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is…
|
+6 | 10 | 41k | 11mo |
|
UK access routes, dated and sourced — a second dataset
Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
|
+76 | 82 | 25k | 14mo |
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
+70 | 74 | 7k | 8mo |
|
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…
|
2 | 44k | 22mo | |
|
EU-wide position versus national implementation — what changed since
EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included,…
|
+22 | 26 | 58k | 2mo |